IGM Biosciences, Inc.
MULTIMERIC GITR BINDING MOLECULES AND USES THEREOF
Last updated:
Abstract:
This disclosure provides dimeric, pentameric, and hexameric GITR agonist binding molecules and methods of using such binding molecules to induce anti-tumor immunity.
Status:
Application
Type:
Utility
Filling date:
24 Feb 2022
Issue date:
9 Jun 2022